Drugs Pharma

AbbVie’s drug-resistant abdominal infection medicine gets US nod

HQ Team February 10, 2025: The U.S. Food and Drug Administration (FDA) has approved Emblaveo, a new antibiotic combination of aztreonam and avibactam,.

Read More
Health Medical Pharma

Globus Medical Inc to buy US-based Nevro Corp for $250 million all cash

Globus Medical, a US-based medical device company, will buy Nevro Corp. for $250 million in an all-cash deal.

Read More
Health Pharma

Medtronic’s brain fluid drainage systems face urgent FDA recall

HQ Team February 6, 2025: The U.S. Food and Drug Administration (FDA) issued a critical Class I recall—the most severe category—for Medtronic’s Becker.

Read More
Health Medical Pharma

Unraveling the link between depression and carbohydrate cravings

Bharti Jayshankar February 5, 2025: Depression, a mental health condition affecting over 280 million people worldwide, is often accompanied by significant changes in.

Read More
Health Medical Pharma

EssilorLuxottica gets regulator nod for audio glasses in US, EU for hearing loss

Franco-Italian EssilorLuxottica SA got approval from the Food and Drug Administration to market its over-the-counter audio glasses in the US for people with.

Read More
Health Medical Pharma

Zimmer Biomet to buy Paragon 28 for $1.1b to expand musculoskeletal care

Zimmer Biomet Holdings, Inc., a US medical device maker, will acquire Paragon 28 Inc., for $1.1 billion to expand into musculoskeletal care, according.

Read More
Drugs Health Pharma

US aid pause to take ‘world back to 1980s, 1990s’ on fighting HIV: WHO 

A US government’s decision to pause funding for HIV programmes in low and middle-income countries will take the world back to the 1980s.

Read More
Drugs Health Pharma

AstraZeneca-Daiichi’s breast cancer drug gets broader US nod

Anglo-Swedish AstraZeneca Plc., and Japan’s Daiichi Sankyo’s therapy to treat a certain form of breast cancer has been approved by the US drug.

Read More
Drugs Health Medical Pharma

Biogen-Eisai’s Alzheimer’s drug gets 4-weekly dosing nod in US

Biogen Inc. and its Japanese partner, Eisai Co. Ltd., announced that the US regulator had approved four-weekly maintenance dosing for its Alzheimer's drug.

Read More
Drugs Pharma

AstraZeneca to invest $570 million in Canada to boost innovation, clinical delivery

HQ Team January 26, 2025: Pharmaceutical giant AstraZeneca has announced plans to invest US$570 million in Canada over the next decade, positioning the.

Read More